Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Disc Medicine Inc.

IRON
Current price
59.46 USD -1.27 USD (-2.09%)
Last closed 60.67 USD
Company
ISIN US2546041011
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 1 932 177 024 USD
Yield for 12 month +22.95 %
1Y
3Y
5Y
10Y
15Y
IRON
21.11.2021 - 28.11.2021

Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. The company's preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Disc Medicine, Inc. was founded in 2017 and is headquartered in Watertown, Massachusetts. Address: 321 Arsenal Street, Watertown, MA, United States, 02472

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

89.33 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-100 000 USD

Last Year

-300 000 USD

Current Quarter

-110 000 USD

Last Quarter

-26 000 USD

Key Figures IRON

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -110 800 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -15.51 %
PEG Ratio
Return On Equity TTM -21.16 %
Wall Street Target Price 89.33 USD
Revenue TTM
Book Value 16.45 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -3.62 USD
Diluted Eps TTM -3.62 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics IRON

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History IRON

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:30
Payout Ratio
Last Split Date 30.12.2022
Dividend Date

Stock Valuation IRON

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -7.5607
Price Book MRQ 3.9527

Financials IRON

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators IRON

For 52 weeks

25.6 USD 77.6 USD
50 Day MA 49.94 USD
Shares Short Prior Month 1 589 329
200 Day MA 47.53 USD
Short Ratio 6.16
Shares Short 1 477 651
Short Percent 5.65 %